Subendocardial Viability Ratio in Hypertension

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The aim of the research is to evaluate the Subendocardial Viability Ratio (SEVR) in hypertensive patients, using non-invasive arterial tonometry, and to establish the influencing factors and the possibility of predicting cardiovascular morbidity and mortality in arterial hypertension. The SEVR will be evaluated on all patients belonging to the Arterial Hypertension Centers undergoing non-invasive arterial tonometry. The SEVR is calculated on the morphology of the central pressure wave as the ratio between the DPTI (diastolic pressure-time index), i.e. the area between the carotid pressure curve and the ventricular pressure curve during the diastolic phase, and the SPTI ( systolic pressure-time index), i.e. the area under the carotid pressure curve during the systolic phase. The SEVR will be correlated with the anthropometric and pathology variables which will be collected in an appropriate database.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Hypertension

Locations
Other Locations
Italy
Unità Operativa Semplice Dipartimentale Ipertensione Arteriosa Anna Maria Pirrelli, Università degli Studi di Bari Aldo Moro. Policlinico Consorziale di Bari
RECRUITING
Bari
Centro di Prevenzione e Cura dell'Ipertensione Arteriosa Alessandro Filippi
RECRUITING
Mascalucia
Istituto Auxologico Italiano IRCCS
RECRUITING
Milan
Medicina II Cardiovascolare, AUSL-IRCCS di Reggio Emilia
RECRUITING
Reggio Emilia
Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università degli studi di Trieste
RECRUITING
Trieste
Contact Information
Primary
Paolo Salvi, MD
p.salvi@auxologico.it
+390261911
Time Frame
Start Date: 2022-10-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 3000
Related Therapeutic Areas
Sponsors
Leads: Istituto Auxologico Italiano

This content was sourced from clinicaltrials.gov